"Dapagliflozin and Metformin"

Dapagliflozin and Metformin
GLIDAPAFLOZIN M are both medications used to manage type 2 diabetes. They work through different mechanisms to help lower blood sugar levels and improve glycemic control. These medications are sometimes prescribed together as a combination therapy to provide complementary effects. Here's an overview of each medication and their combination:
Dapagliflozin:
Mechanism of Action: Dapagliflozin belongs to the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors. It works by inhibiting the reabsorption of glucose in the kidneys, leading to increased urinary excretion of glucose and lowering blood sugar levels.
Indications: Dapagliflozin is used to improve glycemic control in adults with type 2 diabetes.
Benefits: Apart from its glucose-lowering effects, dapagliflozin has been associated with potential benefits such as weight loss and reductions in blood pressure. It promotes glucose excretion in the urine, making it especially useful for people with elevated blood sugar levels.
Dosage and Administration: Dapagliflozin is typically taken as an oral tablet once daily.
Metformin:
Mechanism of Action: Metformin is a biguanide medication that primarily works by reducing the production of glucose by the liver, improving insulin sensitivity in muscle cells, and decreasing glucose absorption from the intestines.
Indications: Metformin is commonly used to manage blood sugar levels in individuals with type 2 diabetes.
Benefits: In addition to its glucose-lowering effects, metformin has been associated with potential benefits such as modest weight loss and a decreased risk of cardiovascular events.
Dosage and Administration: Metformin is taken orally as a tablet, typically one to three times a day, with meals.
Combination of GLIDAPAFLOZIN M:
GLIDAPAFLOZIN M are often prescribed together as a combination therapy for individuals with type 2 diabetes.
The combination leverages the benefits of both medications: dapagliflozin's ability to increase urinary glucose excretion and metformin's effects on reducing glucose production and improving insulin sensitivity.
The combined action can result in improved glycemic control, weight management, and reduction in cardiovascular risk factors.
For further information please contact:
info@sterispharma.com
order now: https://www.sterisonline.com/product/glidapaflozin-m-5-500-133424